phosphoramidon

endothelin converting enzyme 1 ; Homo sapiens







43 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33917140 Therapeutic Effect of Endothelin-Converting Enzyme Inhibitor on Chronic Kidney Disease through the Inhibition of Endoplasmic Reticulum Stress and the NLRP3 Inflammasome. 2021 Apr 7 1
2 26996808 New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes. 2016 May 1
3 24000822 Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies. 2014 3
4 21174590 Endothelin-1 expression by vascular endothelial growth factor in human umbilical vein endothelial cells and aortic smooth muscle cells. 2011 1
5 18992253 Structure of human endothelin-converting enzyme I complexed with phosphoramidon. 2009 Jan 9 1
6 19151386 Functional and molecular characterization of the endothelin system in retinal arterioles. 2009 Jul 1
7 17643133 The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1. 2007 Oct 2
8 15969636 Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line. 2005 Jun 2
9 15151517 Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. 2004 Jun 1
10 12827039 The effects of phosphoramidon on the expression of human endothelin-converting enzyme-1 (ECE-1) isoforms. 2003 Jul 5
11 12193062 Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1. 2002 Aug 1
12 12477147 Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes. 2002 Fall 2
13 11078325 Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH. 2000 Nov 2
14 11099107 Modulation of endothelin-1 in normal human keratinocytes by UVA1/B radiations, prostaglandin E2 and peptidase inhibitors. 2000 Dec 1
15 11145756 Selective upregulation of endothelin converting enzyme-1a in the human failing heart. 2000 Dec 1
16 10217651 Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. 1999 Apr 27 1
17 10222335 Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. 1999 Apr 30 4
18 10352019 Cyclic expression of endothelin-converting enzyme-1 mediates the functional regulation of seminiferous tubule contraction. 1999 May 31 2
19 10455291 Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells. 1999 Jul 1
20 9515580 In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. 1998 Mar 1 2
21 9533826 Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-alpha. 1998 Jan 1
22 9595400 Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities. 1998 1
23 9595528 Phosphoramidon-sensitive and -insensitive endothelin-converting enzyme in human megakaryoblastic cell lines. 1998 1
24 8994440 Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. 1997 Jan 7 1
25 9422810 Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. 1997 Dec 1
26 8828809 Characterization of endothelin converting enzyme from intact cells of a permanent human endothelial cell line, EA.hy926. 1996 Jun 1
27 8901663 Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. 1996 Nov 1 1
28 7550091 Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells. 1995 Mar 4
29 7857289 A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. 1995 Feb 6 2
30 7864859 Selective proteolitic activation and degradation of ETs and big ETs in parenchymal strips of the guinea-pig lung. 1995 Feb 15 1
31 8587357 Physiologic role of endothelin in maintenance of vascular tone in humans. 1995 1
32 8587408 Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. 1995 1
33 8587470 Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. 1995 4
34 7949376 A rapid and versatile method for screening endothelin converting enzyme activity. 1994 Aug 1
35 8020872 Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition. 1994 4
36 7509999 Evidence for vesicles that transport endothelin-1 in bovine aortic endothelial cells. 1993 2
37 7510007 Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1. 1993 1
38 8431480 Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane. 1993 Feb 13 1
39 8458433 Endothelin-converting enzyme activity in human serum lipoprotein fraction. 1993 Apr 5 1
40 1282965 Detection by bioassay and specific enzyme-linked immunosorbent assay of phosphoramidon-inhibitable endothelin-converting activity in brain and endothelium. 1992 1
41 1540181 Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. 1992 Feb 14 2
42 1725347 Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1. 1991 2
43 1953706 Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. 1991 Oct 31 1